Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain
about
Transient opening of the perineurial barrier for analgesic drug deliveryThe roles of nerve growth factor and cholecystokinin in the enhancement of morphine analgesia in a rodent model of central nervous system inflammationDevelopmental expression of δ-opioid receptors during maturation of the parasympathetic, sympathetic, and sensory innervations of the neonatal heart: early targets for opioid regulation of autonomic controlSensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system.Chronic hypoxia-induced acid-sensitive ion channel expression in chemoafferent neurons contributes to chemoreceptor hypersensitivity.Effects of pinacidil on changes to the microenvironment around the incision site, of a skin/muscle incision and retraction, in a rat model of postoperative pain.Local Infiltration Analgesia for Postoperative Pain Control following Total Hip Arthroplasty: A Systematic Review.Anti-nerve growth factor antibody attenuates chronic morphine treatment-induced tolerance in the rat.Rab7 silencing prevents μ-opioid receptor lysosomal targeting and rescues opioid responsiveness to strengthen diabetic neuropathic pain therapy.Functional role of peripheral opioid receptors in the regulation of cardiac spinal afferent nerve activity during myocardial ischemia.Impacts of anti-nerve growth factor antibody on pain-related behaviors and expressions of opioid receptor in spinal dorsal horn and dorsal root ganglia of rats with cancer-induced bone pain.Peripheral mechanisms of pain and analgesia.Endomorphin-2 Inhibition of Substance P Signaling within Lamina I of the Spinal Cord Is Impaired in Diabetic Neuropathic Pain Rats.Effect of transdermal opioids in experimentally induced superficial, deep and hyperalgesic pain.Evidence for MOR on cell membrane, sarcoplasmatic reticulum and mitochondria in left ventricular myocardium in rats.New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration.Relative contributions of peripheral versus supraspinal or spinal opioid receptors to the antinociception of systemic opioids.Role of neurotrophins in neuropathic pain.Noise-induced hearing loss: Neuropathic pain via Ntrk1 signalingAttenuation of opioid tolerance by ETB receptor agonist, IRL-1620, is independent of an accompanied decrease in nerve growth factor in micePeripheral non-viral MIDGE vector-driven delivery of beta-endorphin in inflammatory pain.The presence of mu-, delta-, and kappa-opioid receptors in human heart tissue.Cellular localization and adaptive changes of the cardiac delta opioid receptor system in an experimental model of heart failure in rats.Fentanyl decreases discharges of C and A nociceptors to suprathreshold mechanical stimulation in chronic inflammation.Oxycodone regulates incision-induced activation of neurotrophic factors and receptors in an acute post-surgery pain rat model
P2860
Q28568470-B544D9A5-0858-4FB6-82D3-46B0375D6048Q28579164-0F09D3A4-9392-4DB2-B778-70942232F6EFQ28580042-9AD9ADC8-92A3-49DD-850C-D5695E075E94Q34294075-557A0F59-C02F-4D96-B82C-FEF20B4F120FQ35601460-559DAD9F-6273-423F-B433-0B64C696B3B3Q35628486-815D2118-5F9C-4576-88A9-02B6C493B256Q36099842-B83AC123-4064-4007-AD93-570E0391D374Q36123358-AEDD911E-8168-47C0-A8A5-EAF2C790E46DQ36720646-9CE114B4-914E-41CE-9BD4-37B087DAFDDEQ37054959-9A000BD3-F9F5-47AA-A7A8-71BB6D0AC1C4Q37114759-38E9A7F1-4E57-4692-8F3E-8CF6B3188C22Q37314270-8BE6D12F-3592-446C-A16F-6E3825B1886AQ37576894-5D8EE0C2-3317-4816-9D57-DCDC5032716BQ38739959-1B11C74F-64F6-41AB-AEC6-3F96916A4EC5Q38930103-EB118157-2FC4-4269-B86A-D932BF6881C9Q39584305-B240B514-6EF8-4423-9AE8-88F9D553248FQ39652067-74BD3D0B-0BCD-4EBA-8A00-2018209B73D4Q40576520-7DF64865-DC0D-4F38-9E51-DD1543E3BB2EQ40961264-C2306384-9118-4D46-8872-2EDB94A18424Q41882318-D0F426A1-896E-4CDA-BAA6-B2E1DDDC56F5Q42948028-95B498AE-0472-4C4C-9A83-339DB839B029Q44342762-7AF1AC87-B0D3-4161-8757-357665836EA6Q44348967-759C0D28-76CE-4D1A-B005-4A3D17D7D4F2Q48132651-FA84FD5F-3715-4428-814B-8D63EA3353D8Q59126105-3F59DE0B-601D-4758-8E21-433E1F0D62F4
P2860
Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain
description
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2007
@ast
im Februar 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2007/02/01)
@sk
vědecký článek publikovaný v roce 2007
@cs
wetenschappelijk artikel (gepubliceerd op 2007/02/01)
@nl
наукова стаття, опублікована в лютому 2007
@uk
مقالة علمية (نشرت في فبراير 2007)
@ar
name
Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain
@ast
Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain
@en
Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain
@nl
type
label
Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain
@ast
Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain
@en
Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain
@nl
prefLabel
Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain
@ast
Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain
@en
Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain
@nl
P2093
P3181
P356
P1433
P1476
Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain
@en
P2093
Bopaiah P. Cheppudira
Julia Hofmann
Michael Schäfer
Mohammed Shaqura
Oliver Fischer
Rainer Hellweg
Shaaban A. Mousa
P304
P3181
P356
10.1093/BRAIN/AWL330
P407
P577
2007-02-01T00:00:00Z